Red-green color vision impairment in Duchenne muscular dystrophy

American Journal of Human Genetics

Volumn 80, Issue 6, 2007, Pages 1064-1075

  Costa, Marcelo Fernandes ^a   Oliveira, Andre Gustavo Fernandes ^a   Feitosa Santana, Claudia ^a   Zatz, Mayana ^a   Ventura, Dora Fix ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; ISOPROTEIN;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; COLOR VISION; COLOR VISION DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DUCHENNE MUSCULAR DYSTROPHY; EXON; FEMALE; GENE DELETION; HUMAN; MALE; PRIORITY JOURNAL; PROMOTER REGION; RETINA DISEASE; RETINA IMAGE; SCHOOL CHILD; STATISTICAL ANALYSIS; VISION TEST; ADULT; CASE CONTROL STUDY; CHILD; CLASSIFICATION; COLOR VISION TEST; GENETICS; METHODOLOGY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; COLOR PERCEPTION; COLOR PERCEPTION TESTS; COLOR VISION DEFECTS; DYSTROPHIN; EXONS; GENE DELETION; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 34250903575     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/518127     Document Type: Article

References (65)

1. Matsuo M (1996) Duchenne/Becker muscular dystrophy: from molecular diagnosis to gene therapy. Brain Dev 18:167-172
2. Nobile C, Marchi J, Nigro V, Roberts RG, Danieli GA (1997) Exon-intron organization of the human dystrophin gene. Genomics 45:421-424
3. O'Brien KF, Kunkel LM (2001) Dystrophin and muscular dystrophy: past, present, and future. Mol Genet Metab 74:75-88
4. Hoffman EP, Brown RH Jr, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919-928
5. Koenig M, Monaco AP, Kunkel LM (1988) The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53:219-226
6. Pillers DA, Fitzgerald KM, Duncan NM, Rash SM, White RA, Dwinnell SJ, Powell BR, Schnur RE, Ray PN, Cibis GW, et al (1999) Duchenne/Becker muscular dystrophy: correlation of phenotype by electroretinography with sites of dystrophin mutations. Hum Genet 105:2-9
7. Schmitz F, Drenckhahn D (1997) Localization of dystrophin and beta-dystroglycan in bovine retinal photoreceptor processes extending into the postsynaptic dendritic complex. Histochem Cell Biol 108:249-255
8. Claudepierre T, Dalloz C, Mornet D, Matsumura K, Sahel J, Rendon A (2000) Characterization of the intermolecular associations of the dystrophin- associated glycoproteincomplex in retinal Muller glial cells. J Cell Sci 113:3409-3417
9. Claudepierre T, Mornet D, Pannicke T, Forster V, Dalloz C, Bolanos F, Sahel J, Reichenbach A, Rendon A (2000) Expression of Dp71 in muller glial cells: a comparison with utrophin- and dystrophin-associated proteins. Invest Ophthalmol Vis Sci 41:294-304
10. Connors NC, Kofuji P (2002) Dystrophin Dp71 is critical for the clustered localization of potassium channels in retinal glial cells. J Neurosci 22:4321-4327
11. Schmitz F, Drenckhahn D (1997) Dystrophin in the retina. Prog Neurobiol 53:547-560
12. Ueda H, Baba T, Terada N, Kato Y, Tsukahara S, Ohno S (1997) Dystrophin in rod spherules; submembranous dense regions facing bipolar cell processes. Histochem Cell Biol 108:243-248
13. Ueda H, Tsukahara S, Kobayashi T, Ohno S (1995) Immunocytochemical study of dystrophin-related protein in the rat retina. Ophthalmic Res 27:219-226
14. Pillers DA, Bulman DE, Weleber RG, Sigesmund DA, Musarella MA, Powell BR, Murphey WH, Westall C, Panton C, Becker LE, et al (1993) Dystrophin expression in the human retina is required for normal function as defined by electroretinography. Nat Genet 4:82-86
15. Pillers DM, Sigesmund DA, Ray PN, Musarella MA, Tremblay F, Seltzer WK, Powell B, Mccabe ERB, Schnur RE, Panton C, et al (1993) Genotype-phenotype correlations identified by electrophysiology of the retina in Duchenne and Becker muscular-dystrophy patients. Am J Hum Genet Suppl 53:A146
16. Fitzgerald KM, Cibis GW, Harris DJ, Rothberg PG (1993) Onresponses and off-responses of the photopic ERG in Duchenne muscular-dystrophy and congenital stationary night blindness. Invest Ophthalmol Vis Sci 34:1076
17. Fitzgerald KM, Cibis GW, Gettel AH, Rinaldi R, Harris DJ, White RA (1999) ERG phenotype of a dystrophin mutation in heterozygous female carriers of Duchenne muscular dystrophy. J Med Genet 36:316-322
18. Tremblay F, De Becker I, Riddell DC, Dooley JM (1994) Duchenne muscular dystrophy: negative scotopic bright-flash electroretinogram and normal dark adaptation. Can J Ophthalmol 29:280-283
19. De Becker I, Riddell DC, Dooley JM, Tremblay F (1994) Correlation between electroretinogram findings and molecular analysis in the Duchenne muscular-dystrophy phenotype. Br J Ophthalmol 78:719-722
20. D'Souza VN, Nguyen TM, Morris GE, Karges W, Pillers DA, Ray PN (1995) A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet 4:837-842
21. Drenckhahn D, Holbach M, Ness W, Schmitz F, Anderson LV (1996) Dystrophin and the dystrophin-associated glycoprotein, beta-dystroglycan, co-localize in photoreceptor synaptic complexes of the human retina. Neuroscience 73:605-612
22. Pascual Pascual SI, Molano J, Pascual-Castroviejo I (1998) Electroretinogram in Duchenne/Becker muscular dystrophy. Pediatr Neurol 18:315-320
23. Yang Y, Zhang C, Sheng W, Pan S, Wu D, Jiang F (2001) Correlation between electroretinographic findings, clinical phenotypic and genotypic analysis in Duchenne and Becker muscular dystrophy. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18:32-34
24. Green DG, Guo H, Pillers DA (2004) Normal photoresponses and altered b-wave responses to APB in the mdxCv3 mouse isolated retina ERG supports role for dystrophin in synaptic transmission. Vis Neurosci 21:739-747
25. Pillers DAM, Weleber RG, Green DG, Rash SM, Dally GY, Howard PL, Powers MR, Hood DC, Chapman VM, Ray PN, et al (1999) Effects of dystrophin isoforms on signal transduction through neural retina: genotype-phenotype analysis of Duchenne muscular dystrophy mouse mutants. Mol Genet Metab 66:100-110
26. Zatz M, Itskan SB, Sanger R, Frota-Pessoa O, Saldanha PH (1974) New linkage data for the X-linked types of muscular dystrophy and G6PD variants, colour blindness, and Xg blood groups. J Med Genet 11:321-327
27. Sigesmund DA, Weleber RG, Pillers DA, Westall CA, Panton CM, Powell BR, Heon E, Murphey WH, Musarella MA, Ray PN (1994) Characterization of the ocular phenotype of Duchenne and Becker muscular dystrophy. Ophthalmology 101:856-865
28. Birch EE, O'Connor AR (2001) Preterm birth and visual development. Semin Neonatol 6:487-497
29. Birch J (2001) Diagnosis of defective colour vision. Buttenworth- Heinemann, Oxford, United Kingdom
30. Mollon JD, Reffin JP (1989) A computer-controlled colour vision test that combines the principles of Chibret and of Stilling. J Physiol Lond 414:5
31. Ventura DF, Costa MF, Gualtieri M, Nishi M, Bernick M, Bonci DM, de Souza J (2003) Early vision loss in diabetic patients assessed by the Cambridge Colour Test. In: Mollon JD, Pokorny J, Knoblauch K (eds) Normal and defective colour vision, 1st ed. Oxford University Press, New York, pp 395-403
32. Ventura DF, Silveira LC, Rodrigues AR, de Souza J, Gualtieri M, Bonci DM, Costa MF (2003) Preliminary norms for the Cambridge Colour Test. In: Mollon JD, Pokorny J, Knoblauch K (eds) Colour and defective colour vision, 1st ed. Oxford University Press, New York, pp 331-339
33. Ventura DF, Costa MTV, Costa MF, Berezovsky A, Salomao SR, Simoes AL, Lago M, Pereira LHMC, Faria MAM, de Souza JM, et al (2004) Multifocal and full-field electroretinogram changes associated with color-vision loss in mercury vapor exposure. Vis Neurosci 21:421-429
34. Ventura DF, Simoes AL, Tomaz S, Costa MF, Lago M, Costa MTV, Canto-Pereira LHM, de Souza JM, Faria MAM, Silveira LCL (2005) Colour vision and contrast sensitivity losses of mercury intoxicated industry workers in Brazil. Environ Toxicol Pharmacol 19:523-529
35. Castelo-Branco M, Faria P, Forjaz V, Kozak LR, Azevedo H (2004) Simultaneous comparison of relative damage to chromatic pathways in ocular hypertension and glaucoma: correlation with clinical measures. Invest Ophthalmol Vis Sci 45:499-505
36. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT (1988) Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res 16:11141-11156
37. Beggs AH, Koenig M, Boyce FM, Kunkel LM (1990) Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 86:45-48
38. Vignos PJ Jr (1967) Diagnosis of progressive muscular dystrophy. J Bone Joint Surg Am 49:1212-1220
39. Regan BC, Reffin JP, Mollon JD (1994) Luminance noise and the rapid determination of discrimination ellipses in colour deficiency. Vision Res 34:1279-1299
40. Pokorny J (1981) Procedures for testing colour vision - report of working group 41. Committee on Vision, Assembly of Behavioral and Social Sciences, National Research Council. National Academy Press, Washington D.C.
41. Siegel IM (1981) The X-Chrom lens: on seeing red. Surv Ophthalmol 25:312-324
42. Knoblauch K, Vital-Durand F, Barbur JL (2001) Variation of chromatic sensitivity across the life span. Vision Res 41:23-36
43. Fitzgerald KM, Cibis GW, Giambrone SA, Harris DJ (1994) Retinal signal transmission in Duchenne muscular dystrophy: evidence for dysfunction in the photoreceptor depolarizing bipolar cell pathway. J Clin Invest 93:2425-2430
44. Sigesmund DA, Ray PN, Pillers DM, Weleber RG, Westall CA, Panton CM, Musarella MA (1993) Duchenne muscular-dystrophy (dmd): severity of rod dysfunction correlates with location of deletion in dmd gene. Invest Ophthalmol Vis Sci 34:1463
45. Pillers DA, Weleber RG, Woodward WR, Green DG, Chapman VM, Ray PN (1995) mdxCv3 mouse is a model for electroretinography of Duchenne/Becker muscular dystrophy. Invest Ophthalmol Vis Sci 36:462-466
46. Cibis GW, Fitzgerald KM, Harris DJ Rothberg PG, Rupani M (1993) The effects of dystrophin gene mutations on the ERG in mice and humans. Invest Ophthalmol Vis Sci 34:3646-3652
47. Benoff K, Fitzgerald K, Zemon V, Pinkhasov E, Gordon J, Cibis G (2001) Magnocellular ON-pathway deficits in Duchenne muscular dystrophy: a visual evoked potential study. Invest Ophthalmol Vis Sci 42:S787
48. Fitzsimmons JS, McLachlan JI, Reeves WG, Marriott DW, Woolfson AM, Mayhew J (1980) Carrier detection in Duchenne muscular dystrophy. J Med Genet 17:165-169
49. Ino-ue M, Honda S, Nishio H, Matsuo M, Nakamura H, Yamamoto M (1997) Genotype and electroretinal heterogeneity in Duchenne muscular dystrophy. Exp Eye Res 65:861-864
50. Girlanda P, Quartarone A, Buceti R, Sinicropi S, Macaione V, Saad FA, Messina L, Danieli GA, Ferreri G, Vita G(1997) Extramuscle involvement in dystrophinopathies: an electroretinography and evoked potential study. J Neurol Sci 146:127-132
51. Neitz M, Neitz J (2000) Molecular genetics of color vision and color vision defects. Arch Ophthalmol 118:691-700
52. Dobkins KR, Gunther KL, Peterzell DH (2000) What covariance mechanisms underlie green/red equiluminance, luminance contrast sensitivity and chromatic (green/red) contrast sensitivity? Vision Res 40:613-628
53. Lee BB (2004) Paths to colour in the retina. Clin Exp Optom 87:239-248
54. Schiller PH (1995) The ON and OFF channels of the mammalian visual system. Prog Retin Eye Res 15:173-195
55. De Valois RL, Abramov I, Jacobs GH (1966) Analysis of response patterns of LGN cells. J Opt Soc Am 56:966-977
56. Diller L, Packer OS, Verweij J, McMahon MJ, Williams DR, Dacey DM (2004) L and M cone contributions to the midget and parasol ganglion cell receptive fields of macaque monkey retina. J Neurosci 24:1079-1088
57. De Valois RL, Cottaris NP, Elfar SD, Mahon LE, Wilson JA (2000) Some transformations of color information from lateral geniculate nucleus to striate cortex. Proc Natl Acad Sci USA 97:4997-5002
58. Dacey DM, Packer OS (2003) Colour coding in the primate retina: diverse cell types and cone-specific circuitry. Curr Opin Neurobiol 13:421-427
59. Calkins DJ (2001) Seeing with S cones. Prog Retin Eye Res 20:255-287
60. Regan BC, Freudenthaler N, Kolle R, Mollon JD, Paulus W (1998) Colour discrimination thresholds in Parkinson's disease: results obtained with a rapid computer-controlled colour vision test. Vision Res 38:3427-3431
61. Simunovic MP, Votruba M, Regan BC, Mollon JD (1998) Colour discrimination ellipses in patients with dominant optic atrophy. Vision Res 38:3413-3419
62. Ventura DF, Silveira LCL, Nishi M, Costa MF, Gualtieri M, Santos RMA, Pinto CT, Moura ALA, Rodrigues AR, Sakurada C, et al (2004) Color vision loss in patients treated with chloroquine. Arq Bras Oftalmol 66:9-15
63. Costa MF, Ventura DF, Perazzolo F, Murakoshi MT, Silveira LCL (2006) Absence of binocular summation, eye dominance and learning effects in color discrimination. Vis Neurosci 23:461-469
64. Ventura DF, Quiros P, Carelli V, Salomao SR, Gualtieri M, Oliveira AG, Costa MF, Berezovsky A, Sadun F, De Negri AM, et al (2005) Chromatic and luminance contrast sensitivities in asymptomatic carriers from a large Brazilian pedigree of 11778 Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci 46:4809-4814
65. Ventura DF, Gualtieri M, Oliveria AGF, Costa MF, Quiros P, Sadun F, de Negri AM, Salomão SR, Berezovsky A, Sherman J, Sadun AA, Carelli V (2007) Male prevalence for acquired color vision defects in asymptomatic carriers of Leber's hereditary optic neuropathy. Invest Ophthalmol Vis Sci 39:2362-2370